All Stories

  1. COVID-19 vaccination does not affect male sexual functions
  2. The correlation between MDM2 SNP309 T > G polymorphism and hepatocellular carcinoma risk – A meta-analysis
  3. Defining vitamin D deficiency in patients with sickle cell disease; A meta-analysis
  4. SLCO1B1 and ABCB1 variants synergistically influence the atorvastatin treatment response in South Indian coronary artery disease patients
  5. Linc-ROR genetic variants are associated with the advanced disease in oral squamous cell carcinoma
  6. Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases
  7. NOS3 gene intron 4 a/b polymorphism is associated with ESRD in autosomal dominant polycystic kidney disease patients
  8. Reply: Clinical studies on coronavirus disease 2019 (COVID-19) in the WHO registry network
  9. ACE I/D polymorphism is not a genetic modifier of renal features in sickle cell anemia patients
  10. IL-18 Gene Promoter Polymorphisms are Involved in Periodontal Disease: A Meta-Analysis
  11. Influence of Neuropeptide Y and Neuropeptide Y 2 Receptor Variants in Acute Coronary Syndrome
  12. Gender differences in the relationship between alcohol consumption and gastric cancer risk are uncertain and not well-delineated
  13. Association Between MTHFD1 1958G > A Variant and non-Syndromic Cleft lip and Palate: An Updated Meta-Analysis
  14. SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted
  15. Interleukin-6 gene -174G>C promoter polymorphism reduces the risk of periodontitis in Brazilian populations: A meta-analysis
  16. The M235T polymorphism in the angiotensinogen gene is not a major risk factor for diabetic nephropathy; a meta-analysis
  17. IL1RN VNTR Polymorphism and kidney damage in sickle cell anemia patients
  18. Meta-Analysis on the Association of Neuropeptide Y rs16139 Variant With the Risk of Alcoholism
  19. Molecular docking study of Momordica charantia Linn phytoconstituent with caspase 3 and implications for renoprotective actions in diabetes mellitus
  20. Physical Activity and Nutritional Influence on Immune Function: An Important Strategy to Improve Immunity and Health Status
  21. Sodium-glucose co-transporter 2 inhibitors (SGLT2i); as a preventive factor of kidney failure in patients with type 2 diabetes; a meta-analysis of randomized controlled trials
  22. Ameliorative impact of sodium–glucose cotransporter-2 inhibitors in diabetic kidney disease; a mini- review to current evidence
  23. The HBG2 rs7482144 (C > T) Polymorphism is Linked to HbF Levels but not to the Severity of Sickle Cell Anemia
  24. World Kidney Day 2021 with the theme of living well with kidney disease; a review of current concepts
  25. A Review on Hematopoietic Stem Cell Treatment for Epilepsy
  26. Association of hypercoagulation with severe acute respiratory syndrome coronavirus 2 infection
  27. Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science
  28. Susceptibility to vascular complications in sickle cell anemia patients is associated with intron 4a/b polymorphism of the NOS3 gene: A meta-analysis
  29. Genetic variations at 10q26 regions near FGFR2 gene and its association with non-syndromic cleft lip with or without cleft palate
  30. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings
  31. Engineered nanoparticles for imaging and drug delivery in colorectal cancer
  32. Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective
  33. Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy
  34. Genetic association of GSTM1, GSTT1, and GSTP1 polymorphisms with sickle cell disease complications: A systematic review and meta-analysis
  35. COVID-19 and the kidney; mechanisms of tubular injury by SARS-CoV-2
  36. Understanding kidney injury in COVID-19; a pressing priority
  37. Interleukin-10 gene promoter variants and susceptibility to diabetic nephropathy; a meta-analysis
  38. Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson’s Disease
  39. Potential of renin-angiotensin system inhibition to improve metabolic bone disorders
  40. Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19)
  41. Dynamic Propagation and Impact of Pandemic Influenza A (2009 H1N1) in Children: A Detailed Review
  42. Metformin induced acute kidney injury; a systematic review
  43. Strive for kidney health for everyone during COVID-19; the possible theme for the world kidney day 2021
  44. HIF1A C1772T genetic variation is associated with the elevated risk of breast cancer among Asians: An updated meta-analysis
  45. MicroRNA a small magic bullet for gastric cancer
  46. Glomerulonephritis associated with SARS-CoV-2 infection
  47. Parental transmission effect of PDGF-C gene variants on non-syndromic cleft lip with or without cleft palate
  48. Herbal antioxidants and renal ischemic-reperfusion injury; an updated review
  49. Perspectives on the relationship of renal disease and coronavirus disease 2019
  50. Coronavirus-nephropathy; renal involvement in COVID-19
  51. Meta-analysis of NFKB1 -94 ATTG ins/del polymorphism and risk of breast cancer
  52. Association between functional TERT promoter polymorphism rs2853669 and cervical cancer risk in South Indian women
  53. Maternal and infant MTHFR gene polymorphisms and non-syndromic oral cleft susceptibility: An updated meta-analysis
  54. A Retrospective Look at Anti-EGFR Agents in Pancreatic Cancer Therapy
  55. Micro RNA facilitated chemoresistance in gastric cancer: a novel biomarkers and potential therapeutics
  56. The Fuzzy Connection between SARS-CoV-2 Infection and Loss of Renal Function
  57. Tumor Necrosis Factor-Alpha Gene Promoter (TNF-α G-308A) Polymorphisms Increase the Risk of Hepatocellular Carcinoma in Asians: A Meta-Analysis
  58. Administration of metformin in type 2 diabetes mellitus patients with chronic kidney disease; facts and myths
  59. Apolipoprotein L1 associated nephropathy; an overview
  60. Association between MTHFR 677C>T polymorphism and vascular complications in sickle cell disease: A meta-analysis
  61. The K469E genetic variant in the ICAM1 gene is associated with type 2 diabetes but not with its vascular complications: a meta-analysis
  62. Genetic association of ACE gene I/D polymorphism with the risk of diabetic kidney disease; a meta-analysis
  63. Association between the methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms and the risk of diabetic nephropathy; a meta-analysis
  64. Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troubles
  65. Clinical and Immunogenetic Aspects of Systemic Lupus Erythematosus
  66. Pain Management Issues as Part of the Comprehensive Care of Patients with Sickle Cell Disease
  67. Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India
  68. Cyclic Guanosine Monophosphate-Dependent Protein Kinase I Stimulators and Activators Are Therapeutic Alternatives for Sickle Cell Disease
  69. Reply to comment on: “Ocular manifestations of sickle cell disease and genetic susceptibility for refractive errors”
  70. Drug Resistance Against Tyrosine Kinase Inhibitor in Gastrointestinal Malignancies
  71. Transmission analysis of TGFB1 gene polymorphisms in non-syndromic cleft lip with or without cleft palate
  72. IRF6 rs2235375 single nucleotide polymorphism is associated with isolated non-syndromic cleft palate but not with cleft lip with or without palate in south Indian population
  73. Attitudes and beliefs among high- and low-risk population groups towards β-thalassemia prevention: a cross-sectional descriptive study from India
  74. Presence of atypical beta globin ( HBB ) gene cluster haplotypes in sickle cell anemia patients of India
  75. Ocular manifestations of sickle cell disease and genetic susceptibility for refractive errors
  76. Aldosterone synthase gene is not a major susceptibility gene for progression of chronic kidney disease in patients with autosomal dominant polycystic kidney disease
  77. Current perspectives on velocardiofacial syndrome
  78. NOS3 27-bp and IL4 70-bp VNTR Polymorphisms Do Not Contribute to the Risk of Sickle Cell Crisis
  79. Association of TFAP2A gene polymorphism with susceptibility to non-syndromic cleft lip with or without palate risk in south Indian population
  80. Polymorphic Regions in Fc Gamma Receptor and Tumor Necrosis Factor-α Genes and Susceptibility to Chronic Periodontitis in a Cohort From South India
  81. Role of myosin 1H gene polymorphisms in mandibular retrognathism
  82. ECE1 gene variant shows tendency toward chronic kidney disease advancement among autosomal polycystic kidney disease patients
  83. Uitspraak rechtbank inzake Brink’s Nederland BV – Geldservice Nederland BV
  84. Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD
  85. Influence of angiotensin converting enzyme (ACE) gene rs4362 polymorphism on the progression of kidney failure in patients with autosomal dominant polycystic kidney disease (ADPKD)
  86. Polymorphic variants near 1p22 and 20q11.2 loci and the risk of non-syndromic cleft lip and palate in South Indian population
  87. Genetic variant in MTRR A66G, but not MTR A2756G, is associated with risk of non-syndromic cleft lip and palate in Indian population
  88. Burden among Parkinson's disease care givers for a community based study from India
  89. Angiotensinogen gene polymorphisms and progression of chronic kidney disease in ADPKD patients
  90. Two promoter polymorphisms in TBX22 are associated with the risk of NSCLP in Indian women
  91. Genotyping and meta-analysis of KIF6 Trp719Arg polymorphism in South Indian Coronary Artery Disease patients: A case–control study
  92. SATB2 gene variants in non-syndromic cleft lip with or without cleft palate in Indian population
  93. Insights on the structural perturbations in human MTHFR Ala222Val mutant by protein modeling and molecular dynamics
  94. Evidence of the involvement of the polymorphisms near MSX1 gene in non-syndromic cleft lip with or without cleft palate
  95. Polymorphic Regions in the Interleukin-1 Gene and Susceptibility to Chronic Periodontitis: A Genetic Association Study
  96. CBS c.844ins68 Polymorphism Frequencies in Control Populations: Implications on Nonsyndromic Cleft Lip With or Without Cleft Palate
  97. TYMS gene 5'- and 3'-untranslated region polymorphisms and risk of non-syndromic cleft lip and palate in an Indian population
  98. NAT2 genetic variations among South Indian populations
  99. Związek między polimorfizmem rs7903146 genu TCF7L2 a nefropatią cukrzycową nie jest niezależny od cukrzycy typu 2 — badanie populacji Indii Południowych i metaanaliza
  100. NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease
  101. Relationship between reduced folate carrier gene polymorphism and non-syndromic cleft lip and palate in Indian population
  102. MTHFR C677T and A1298C polymorphisms and risk of nonsyndromic orofacial clefts in a south Indian population
  103. Significant association of MTHFD1 1958G A single nucleotide polymorphism with nonsyndromic cleft lip and palate in Indian population
  104. EPHX1 gene polymorphisms among south Indian populations
  105. Lack of association between IRF6 polymorphisms and nonsyndromic oral clefts in South Indian population
  106. Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review
  107. Polymorphisms in genes encoding dopamine signalling pathway and risk of alcohol dependence: a systematic review
  108. Analysis of Microsatellite Polymorphisms in South Indian Patients with Non Syndromic Cleft Lip and Palate
  109. Role of the ACE ID and PPARG P12A Polymorphisms in Genetic Susceptibility of Diabetic Nephropathy in a South Indian Population
  110. Gene Frequencies of the Human GSTT1 (Null Allele) and GSTP1 (Ile105Val) Polymorphisms among South Indian Populations
  111. HLA class II SNP interactions and the association with type 1 diabetes mellitus in Bengali speaking patients of Eastern India
  112. Functional PstI/RsaI Polymorphisms in the CYP2E1 Gene among South Indian Populations
  113. Endothelial nitric oxide synthase VNTR (intron 4 a/b) polymorphism association with nonsyndromic oral clefts
  114. Association between Neuropeptide Y Gene Polymorphisms and Alcohol Dependence: A Case-Control Study in Two Independent Populations
  115. Dopamine Transporter (DAT1) VNTR Polymorphism and Alcoholism in Two Culturally Different Populations of South India
  116. An unlikely role for the NAT2 genotypes and haplotypes in the oral cancer of south Indians
  117. Molecular Basis of β-Thalassemia in Karnataka, India
  118. EPHX1 Gene Polymorphisms in Alcohol Dependence and their Distribution among the Indian Populations
  119. CYP1A1 genotypes and haplotypes and risk of oral cancer: a case-control study in South Indians
  120. Lack of Association ofEPHX1Genotypes and Haplotypes with Oral Cancer in South Indians
  121. Polymorphisms in genes involved in folate metabolism and orofacial clefts
  122. Apelin gene polymorphism influences apelin expression and obesity phenotypes in Chinese women
  123. Indian Siddis: African Descendants with Indian Admixture
  124. A Novel Polymorphism in Codon 25 of theKRASGene Associated with Gallbladder Carcinoma Patients of the Eastern Part of India
  125. Association Between the M268T Polymorphism in the Angiotensinogen Gene and Essential Hypertension in a South Indian Population
  126. Lack of Association Between the IL-10 Gene Polymorphisms and Features of the Metabolic Syndrome
  127. Population-Based Case-Control Study of DRD2 Gene Polymorphisms and Alcoholism
  128. Neuropeptide Y gene polymorphisms are not associated with obesity in a South Indian population
  129. Neuropeptide Y gene functional polymorphism influences susceptibility to hypertension in Indian population
  130. Dopamine transporter (DAT1) VNTR polymorphism in 12 Indian populations
  131. Current concepts in genetics of nonsyndromic clefts
  132. Genetic heterogeneity in the Indian stocks of seahorse (Hippocampus kuda and Hippocampus trimaculatus) inferred from mtDNA cytochrome b gene
  133. Allelic Variation and Haplotype Structure of the Dopamine Receptor GeneDRD2in Nine Indian Populations
  134. Maternal Footprints of Southeast Asians in North India
  135. Allelic variation in the NPY gene in 14 Indian populations
  136. Single nucleotide polymorphisms in alcohol dehydrogenase genes among some Indian populations
  137. Single nucleotide polymorphisms of the ALDH2 gene in six Indian populations
  138. Genetic affinities among the lower castes and tribal groups of India: inference from Y chromosome and mitochondrial DNA